Zacks Investment Research Upgrades DLH (DLHC) to Hold

DLH (NASDAQ:DLHC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday.

According to Zacks, “DLH Holdings Corp. serves clients throughout the United States as a full-service provider of healthcare, logistics, and technical support services to DoD and Federal agencies. Its healthcare delivery solutions include professional services, such as case management, health and injury assessment, critical care, medical/surgical, emergency room/trauma center, counseling, behavioral health and trauma brain injury, medical systems analysis, and medical logistics, and allied support services in the areas of MRI technology, diagnostic sonography, phlebotomy, dosimetry, physical therapy, and pharmaceuticals. The company’s logistics and technical services include program and project management, systems engineering and applicable information technology services, integrated logistics support, training, equipment and non-tactical vehicle operations and maintenance, and facilities and shipyard support services. DLH Holdings Corp., formerly known as TeamStaff, Inc., is headquartered in Atlanta, Georgia. “

Separately, Noble Financial set a $8.00 price objective on shares of DLH and gave the stock a “buy” rating in a research report on Tuesday, August 7th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. DLH presently has a consensus rating of “Buy” and an average target price of $7.25.

Shares of NASDAQ DLHC opened at $5.85 on Wednesday. DLH has a 52-week low of $5.00 and a 52-week high of $6.83. The company has a market capitalization of $69.61 million, a price-to-earnings ratio of 21.67 and a beta of 0.30.

DLH (NASDAQ:DLHC) last announced its quarterly earnings results on Monday, August 6th. The business services provider reported $0.13 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.10 by $0.03. DLH had a net margin of 0.85% and a return on equity of 12.54%. The firm had revenue of $36.13 million during the quarter, compared to analysts’ expectations of $32.00 million. equities research analysts predict that DLH will post 0.09 earnings per share for the current year.

In other news, insider Kevin Wilson sold 30,000 shares of the stock in a transaction on Wednesday, September 12th. The shares were sold at an average price of $5.00, for a total transaction of $150,000.00. Following the completion of the sale, the insider now directly owns 305,006 shares in the company, valued at $1,525,030. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 25.90% of the company’s stock.

An institutional investor recently raised its position in DLH stock. Dimensional Fund Advisors LP increased its stake in shares of DLH Holdings Corp (NASDAQ:DLHC) by 38.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,093 shares of the business services provider’s stock after acquiring an additional 11,459 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.35% of DLH worth $240,000 at the end of the most recent quarter. 57.48% of the stock is currently owned by institutional investors.

DLH Company Profile

DLH Holdings Corp. provides healthcare and social services in the United States. It offers defense and veterans' health solutions, including case management, physical and behavioral health examinations, and medical administration and logistics services. The company also provides a range of human services and solutions, which consists of educational and environmental support services for the underserved children and youth comprising health, nutritional, parental, and behavioral services; and IT system architecture design, migration plan, and ongoing maintenance services.

Read More: What is a conference call?

Get a free copy of the Zacks research report on DLH (DLHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for DLH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DLH and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply